AAAAAA

   
Results: 1-15 |
Results: 15
Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis
Authors: Vilim, V Vytasek, R Olejarova, M Machacek, S Gatterova, J Prochazka, B Kraus, VB Pavelka, K
Citation: V. Vilim et al., Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis, OSTEO CART, 9(7), 2001, pp. 612-618
Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis
Authors: Ottillinger, B Gomor, B Michel, BA Pavelka, K Beck, W Elsasser, U
Citation: B. Ottillinger et al., Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis, OSTEO CART, 9(3), 2001, pp. 273-280
Re: Pavelka K, Gatterova J, Gallerova V, Urbanova Z, Sedlackova M, Altman R. A 5-year randomized controlled double-blind study of glycosaminoglycan polysulfuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cart 2000;8 : 335-342.Response to letter to the editor
Authors: Pavelka, K
Citation: K. Pavelka, Re: Pavelka K, Gatterova J, Gallerova V, Urbanova Z, Sedlackova M, Altman R. A 5-year randomized controlled double-blind study of glycosaminoglycan polysulfuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cart 2000;8 : 335-342.Response to letter to the editor, OSTEO CART, 9(3), 2001, pp. 287-287
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
Authors: Perricone, MA Morris, JE Pavelka, K Plog, MS O'Sullivan, BP Joseph, PM Dorkin, H Lapey, A Balfour, R Meeker, DP Smith, AE Wadsworth, SC St George, JA
Citation: Ma. Perricone et al., Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium, HUM GENE TH, 12(11), 2001, pp. 1383-1394
The laboratory of quantitative methods in historic monument research at the CTU Prague
Authors: Musilek, L Cechak, T Kubelik, M Pavelka, K Pavlik, M
Citation: L. Musilek et al., The laboratory of quantitative methods in historic monument research at the CTU Prague, RADIAT PH C, 61(3-6), 2001, pp. 725-727
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood
Authors: Desser, L Holomanova, D Zavadova, E Pavelka, K Mohr, T Herbacek, I
Citation: L. Desser et al., Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood, CANC CHEMOT, 47, 2001, pp. S10-S15
Osteonecrosis
Authors: Pavelka, K
Citation: K. Pavelka, Osteonecrosis, BEST PR R C, 14(2), 2000, pp. 399-414
Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis - Results of a two-year study
Authors: Olejarova, M Kupka, K Pavelka, K Gatterova, J Stolfa, J
Citation: M. Olejarova et al., Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis - Results of a two-year study, JOINT BONE, 67(2), 2000, pp. 107-112
A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon (R)) as a structure modifying therapy in osteoarthritis of the hip and knee
Authors: Pavelka, K Gatterova, J Gollerova, V Urbanova, Z Sedlackova, M Altman, RD
Citation: K. Pavelka et al., A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon (R)) as a structure modifying therapy in osteoarthritis of the hip and knee, OSTEO CART, 8(5), 2000, pp. 335-342
Radiographic progression of knee osteoarthritis in a Czech cohort
Authors: Pavelka, K Gatterova, J Altman, RD
Citation: K. Pavelka et al., Radiographic progression of knee osteoarthritis in a Czech cohort, CLIN EXP RH, 18(4), 2000, pp. 473
EULAR recommendations for the management of knee osteoarthritis: report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
Authors: Pendleton, A Arden, N Dougados, M Doherty, M Bannwarth, B Bijlsma, JWJ Cluzeau, F Cooper, C Dieppe, PA Gunther, KP Hauselmann, HJ Herrero-Beaumont, G Kaklamanis, PM Leeb, B Lequesne, M Lohmander, S Mazieres, B Mola, EM Pavelka, K Serni, U Swoboda, B Verbruggen, AA Weseloh, G Zimmermann-Gorska, I
Citation: A. Pendleton et al., EULAR recommendations for the management of knee osteoarthritis: report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), ANN RHEUM D, 59(12), 2000, pp. 936-944
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard
Authors: Becvar, R Urbanova, Z Vlasakova, V Vitova, J Rybar, I Maldyk, H Filipowicz-Sosnowska, A Bernacka, K Mackiewicz, S Gomor, B Rojkovich, B Siro, B Bereczki, J Toth, K Sukenik, S Green, L Ehrenfeld, M Pavelka, K
Citation: R. Becvar et al., Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard, CLIN RHEUMA, 18(4), 1999, pp. 273-278
Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply
Authors: Bresnihan, B Alvaro-Gracia, JM Cobby, M Doherty, M Domljan, Z Emery, P Nuki, G Pavelka, K Rau, R Rozman, B Watt, I Williams, B Aitchison, R McCabe, D Musikic, P
Citation: B. Bresnihan et al., Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply, ARTH RHEUM, 42(8), 1999, pp. 1782-1782
Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol
Authors: Pavelka, K Peliskova, Z Stehlikova, H Ratcliffe, S Repas, C
Citation: K. Pavelka et al., Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol, CLIN DRUG I, 16(6), 1998, pp. 421-429
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Authors: Bresnihan, B Alvaro-Gracia, JM Cobby, M Doherty, M Domljan, Z Emery, P Nuki, G Pavelka, K Rau, R Rozman, B Watt, I Williams, B Aitchison, R McCabe, D Musikic, P
Citation: B. Bresnihan et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, ARTH RHEUM, 41(12), 1998, pp. 2196-2204
Risultati: 1-15 |